✦ LIBER ✦

Absence of exon 15 BRAF germline mutations in familial melanoma

✍ Scribed by Julie Lang; Maureen Boxer; Rona MacKie

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 169 KB
Volume: 21
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.10188

No coin nor oath required. For personal study only.

✦ Synopsis

We have analyzed DNA from peripheral blood of 42 cases of familial melanoma for germline mutations in exon 15 of the BRAF gene. No evidence of mutation was found. We have also analyzed DNA extracted from secondary melanoma from two members of these families. These results were also negative. In addition we have searched for exon 15 BRAF mutations in 24 samples of secondary melanoma from 22 cases of sporadic melanoma and detected the 1796T>A BRAF mutation which leads to a substitution of valine by glutamic acid at position 599 (V599E) in six samples. Peripheral blood DNA from two of these tumor-positive cases of sporadic melanoma were negative for the V599E BRAF mutation. This mutation therefore appears to be a somatic mutation associated with melanoma development and/or progression in a proportion of affected individuals.

📜 SIMILAR VOLUMES

Absence of V599E BRAF mutations in desmo

Absence of V599E BRAF mutations in desmoplastic melanomas

✍ Jon M. Davison; Eli Rosenbaum; Terry L. Barrett; David Goldenberg; Mohammad O. H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

## Abstract ## BACKGROUND Desmoplastic melanoma is an uncommon variant of cutaneous melanoma that mimics soft tissue sarcoma both clinically and morphologically. An activating point mutation of the __BRAF__ oncogene has been identified in a high proportion of conventional cutaneous melanomas, but

Novel nonsense mutation in exon 15 of th

Novel nonsense mutation in exon 15 of the APC gene in one Jewish family

✍ Olga Monakov; Eliahou Shemesh; Simon Bar-Meir; Ephraim Gazit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

Screening of germline mutations in the C

Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study

✍ Anton Platz; Johan Hansson; Ulrik Ringborg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 2 views

Germline mutations within the CDKN2A gene, coding for the cyclin-dependent kinase inhibitor p16, have been detected by screening in 8% of Swedish families with an inheritance of cutaneous melanoma (FMM) and dysplastic nevus syndrome (DNS). Contrastingly, the closely related gene CDKN2B had no diseas

Absence of hereditary mutations in exons

Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma

✍ Donald J. van Meyel; David A. Ramsay; Ann F. Chambers; David R. Macdonald; Dr. J 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

New founder germline mutations of CDKN2A

New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment

✍ Caroline Kannengiesser; Stéphane Dalle; Marie-Thérèse Leccia; Marie Françoise Av 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

## Abstract Germline mutations in the __CDKN2A__ gene have been shown to predispose individuals to cutaneous malignant melanoma. Here, we describe three melanoma‐prone families and one isolated patient affected by multiple melanoma who carried a tandem germline mutation of __CDKN2A__ at the nucleot

Familial adenomatous polyposis coli: Fiv

Familial adenomatous polyposis coli: Five novel mutations in exon 15 of the adenomatous polyposis coli (APC) gene in Italian patients

✍ Maria I. Scarano; Marina De Rosa; Luigi Panariello; Nicola Carlomagno; Gabriele 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Germline mutations within the adenomatous polyposis coli (APC ) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations with